Âé¶¹´«Ã½

Gilead, Feds Resolve HIV Drug Patent Dispute Amid Appeal

By Hailey Konnath ( January 15, 2025, 11:03 PM EST) -- Gilead Sciences and the federal government have agreed to dismiss all claims and counterclaims in a yearslong intellectual property and contract battle over HIV prevention drugs Truvada and Descovy, according to stipulations of voluntary dismissal filed Wednesday in both the Federal Circuit and Delaware federal court....

Âé¶¹´«Ã½360 is on it, so you are, too.

A Âé¶¹´«Ã½360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Âé¶¹´«Ã½360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Âé¶¹´«Ã½360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login